Remove Clinical Trials Remove Safety Remove Therapy
article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

Current clinical trials are investigating: Precision dosing based on genetic markers Personalized cannabinoid ratios for specific conditions Combination therapies with other natural compounds Long-term safety and efficacy data Is Microdosing Right for You?

article thumbnail

Medical Cannabis and Anxiety: Natural Treatment Options

Miss Marijuana

Clinical trials have been looking into both THC and CBD and their individual roles in treating anxiety. Also, therapy or talking to a professional can be incredibly helpful in tackling the root causes of anxiety. Safety first! But high doses? Well, they can sometimes have the opposite effect. The takeaway?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Ketamine Nasal Spray as First and Only Standalone Therapy for Treatment-Resistant Depression

Veriheal

Now, patients affected by TRD – who didn’t respond to at least two other antidepressants – no longer need to use an antidepressant in order to benefit from ketamine-based therapy. If you are curious about ketamine therapy for depression, you may still have questions, such as: How is ketamine different from other antidepressants?

article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

Federal health regulators recently declined to approve the use of the psychedelic drug midomafetamine (3,4-methylenedioxymethamphetamine or MDMA) as a treatment for post-traumatic stress disorder (PTSD), disappointing many advocates who were hopeful for the next breakthrough in the psychedelic therapy movement.

article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. . This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. ABOUT SANTÉ CANNABIS.

article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

article thumbnail

InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

Puff Puff Post

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.